To further verify the relevance of IFRGs to tumor characteristics and the indicating effects, we analyzed and assessed the expression levels of CACYBP in a non-BCa population and patients with BCa with various T-stages at the genetic and protein levels. The gene discussed is CACYBP; the disease is neoplasm.